Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.565
Low: 1.475
Prev. Close: 1.65
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder

Wed, 22nd Apr 2020 15:13

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday, Tuesday and Wednesday and not separately reported by Alliance News:

----------

Shield Therapeutics PLC - pharmaceuticals - Tim Watts promoted to chief executive officer from chief financial officer, replacing the company's founder, Carl Sterritt. Shield said Sterritt, who formed the company in 2008, resigned "following discussions with major shareholders and with mutual agreement". Watts has been CFO since August 2018, previously having served in the same role at Oxford BioMedica PLC. Watts also worked at AstraZeneca PLC for 22 years.

----------

Bunzl PLC - distributor - Hires Vin Murria as non-executive director, starting June 1. Was founder & chief executive officer of Advanced Computer Software Group PLC. She is currently a non-executive director at Softcat PLC, DWF Group PLC and finnCap Group PLC.

----------

Mobile Streams PLC - data analytics platform - Peter Tomlinson resigns as director immediately, having been with the company for 20 years. Tomlinson stepped in as chair of Mobile Streams at the start of 2018, handing over to Nigel Burton late last year as the company raised equity following a vote by shareholders against delisting the company from AIM. Mobile Streams said Wednesday that Tomlinson "took over as chairman during a difficult time and supported the transition to a new management team".

----------

Metro Bank PLC - Gene Lockhart and Stuart Bernau step down as non-executive directors from May 18, replaced by Anne Grim, Ian Henderson, and Nicholas Winsor. Grim was chief customer officer for fund manager Fidelity International Ltd, and also worked for lenders Barclays PLC and Wells Fargo & Co. Henderson is CEO of Australian know-your-customer service provider Kyckr. Prior that he was chief operating officer for private banking businesses at Barclays Wealth and CEO of RBS International at Royal Bank of Scotland Group PLC. Winsor was CEO of several HSBC Holdings PLC businesses. Metro Bank noted its board now will consist of eight independent non-executive directors and two executive directors.

----------

Centrica PLC - Carlos Pascual and Steve Pusey will step down as non-executive directors from the annual general meeting on May 22.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
19 Sep 2018 08:36

Shield Therapeutics irons losses, agrees commercialisation deal

(Sharecast News) - Iron deficiency treatment specialist Shield Therapeutics narrowed losses as revenues grew in the first half of that saw a series of positive developments.

Read more
13 Sep 2018 11:51

Shield Therapeutics Completes Recruitment For Feraccru Trial

LONDON (Alliance News) - Shield Therapeutics PLC said on Thursday it has completed recruitment of patients for the AEGIS-H2H Phase 3b study of oral Feraccru in subjects suffering from inflammatory

Read more
26 Jul 2018 13:05

Shield Therapeutics Appoints Hans-Peter Hasler To Board

LONDON (Alliance News) - Shield Therapeutics PLC, a commercial stage pharmaceutical company, said Thursday that it has appointed Hans-Peter Hasler as non-executive director with immediate is the a

Read more
20 Jun 2018 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25

Read more
14 Jun 2018 13:48

Shield Therapeutics Reports Positive Results From Feraccru Study

LONDON (Alliance News) - Pharmaceutical company Shield Therapeutics PLC said Thursday it has had positive top-line results from its paediatric phase I pharmacokinetics study of its ferric iron is

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
6 Jan 2017 08:12

Shield Therapeutics sees 'encouraging' demand for oral iron product in England, Germany

(ShareCast News) - AIM-listed pharmaceutical Shield Therapeutics saw "encouraging" demand for its oral iron product in the England and Germany. The company said is seeing "very encouraging signals of demand" after only six months since the commercial launch of Feraccru, which treats of iron deficien

Read more
14 Jun 2016 09:17

Shield Therapeutics Reports Widened Pretax Loss In Maiden 2015 Results

Read more
7 Jun 2016 15:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
26 Feb 2016 09:17

Shield Therapeutics Starts Trading, Gets European Feraccru Approval (ALLIPO)

Read more
12 Feb 2016 11:50

Shield Therapeutics Raises GBP32.5 Million In Delayed AIM IPO (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.